- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Imatron wins clearance for angiographic EBT
Ultrafast CT developer Imatron won a victory this month when it received Food and Drug Administration clearance to use its electron beam tomography (EBT) scanner for angiographic applications. With the clearance, South San Francisco, CA-based Imatron can
Ultrafast CT developer Imatron won a victory this month when it received Food and Drug Administration clearance to use its electron beam tomography (EBT) scanner for angiographic applications. With the clearance, South San Francisco, CA-based Imatron can perform electron beam angiography (EBA) of the coronary arteries, a procedure unique to EBT and feasible because of the units scan speed, according to the company.
For angiography, the companys EBT scanner functions as a diagnostic x-ray system that produces 2-D and 3-D images of the heart, blood vessels, and lymphatic system from a set of cross-sectional anatomical images. EBT can also display 3-D images of the heart in cine mode in its angiography capacity. Imatron estimates that the scanner could eliminate the need for roughly 20% to 40% of conventional coronary angiogram procedures each year.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
